Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

D-0277-2025

March 05, 2025

Class II

Product summary

Firm
Rising Pharma Holding, Inc.
Event
Event 96427
Status
Ongoing
Classification
Class II
Quantity
1223 bottles
Official record key
drug-enforcement:D-0277-2025

Official wording

Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Code information: Lot #: DTB23111A, Exp 8/31/2025

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-duloxetine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations